A new tool for assessing hepatitis B treatment eligibility in Africa

Affiliations

¹ Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro BP 18, Burkina Faso. Electronic address: sergeouoba@gmail.com.
² Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro BP 18, Burkina Faso.

Comment

Serge Ouoba et al. Lancet Gastroenterol Hepatol. 2024 Apr.

. 2024 Apr;9(4):277-278.

doi: 10.1016/S2468-1253(24)00006-2. Epub 2024 Feb 15.

¹ Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro BP 18, Burkina Faso. Electronic address: sergeouoba@gmail.com.
² Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro BP 18, Burkina Faso.

No abstract available

Conflict of interest statement

We declare no competing interests.

Development and evaluation of a simple treatment eligibility score (HEPSANET) to decentralise hepatitis B care in Africa: a cross-sectional study.
Minier N, Guingané AN, Okeke E, Sinkala E, Johannessen A, Andersson MI, Davwar P, Desalegn H, Duguru M, Fall F, Mboup S, Maponga T, Matthews PC, Ramírez Mena A, Ndow G, Orlien SMS, Riches N, Seydi M, Sonderup M, Spearman CW, Stockdale AJ, Taljaard J, Vinikoor M, Wandeler G, Lemoine M, Shimakawa Y, Sombié R. Minier N, et al. Lancet Gastroenterol Hepatol. 2024 Apr;9(4):323-332. doi: 10.1016/S2468-1253(23)00449-1. Epub 2024 Feb 15. Lancet Gastroenterol Hepatol. 2024. PMID: 38367633 Free PMC article.